Detection of adalimumab and anti-adalimumab antibodies in patients with rheumatoid arthritis: a comprehensive overview of methodology pitfalls and benefits
Crossref DOI link: https://doi.org/10.1007/s12026-016-8824-8
Published Online: 2016-07-16
Published Print: 2017-02
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Ogrič, Manca
Terčelj, Matic
Praprotnik, Sonja
Tomšič, Matija
Božič, Borut
Sodin-Semrl, Snezna
Čučnik, Saša
License valid from 2016-07-16